Analysis of the Epidemiological Characteristics of Post-stroke Complications and Suggestions for the Optimization of Grass-roots management in Grass-roots Management System

doi:10.12114/j.issn.1007-9572.2021.00.420

Abstract

Abstract: Stroke is the leading cause of death among Chinese residents，with the improvement of hospital treatment level，the number of stroke survivors returning to the community is also increasing.This has greatly increased the demand for primary community health services，but also brought great challenges to the grassroots community health services.This article discusses the risk factors of stroke survivors in the community and the epidemiological characteristics of post-stroke complications，the grass-roots management plan after stroke recommended based on evidence or expert consensus，and how to establish and optimize the grass-roots management system after stroke，which aims to improve existing general medical services and provide suggestions and references for building a coordinated grassroots post-stroke management service system.

Key words: Stroke, Epidemiology, Secondary prevention, Management, Treatment, Rehabilitation, General practice, General practitioners

摘要： 脑卒中位居我国居民各种死亡的首位，随着医院救治水平的提高，回归社区的脑卒中患者也不断增多，这极大增加了基层社区卫生服务需求，也给基层社区卫生服务带来巨大的挑战。本文通过结合回归社区存活脑卒中患者的危险因素和脑卒中后并发症的流行特征、基于证据和专家共识推荐的脑卒中后基层管理方案以及如何建立和优化脑卒中后的基层管理体系三方面内容，探讨如何完善现有的全科医疗服务，以为构建协同的基层脑卒中后管理服务体系提供建议和参考。

关键词: 脑卒中, 流行病学, 二级预防, 管理, 治疗, 康复, 全科医疗, 全科医生

JIANG Bin. Analysis of the Epidemiological Characteristics of Post-stroke Complications and Suggestions for the Optimization of Grass-roots management in Grass-roots Management System　[J]. Chinese General Practice, 2021, 24(12): 1445-1453. DOI: 10.12114/j.issn.1007-9572.2021.00.420.
江滨. 脑卒中后并发症流行特征分析及对基层管理优化建议[J]. 中国全科医学, 2021, 24(12): 1445-1453. DOI: 10.12114/j.issn.1007-9572.2021.00.420.

References

［1］ZHOU M G，WANG H D，ZENG X Y，et al．Mortality，morbidity，and risk factors in China and its provinces，1990—2017：a systematic analysis for the Global Burden of Disease Study 2017［J］．Lancet，2019，394（10204）：1145-1158．DOI：10.1016/s0140-6736（19）30427-1.
［2］WANG W Z，JIANG B，SUN H X，et al．Prevalence，incidence，and mortality of stroke in China：results from a nationwide population-based survey of 480?687 adults［J］．Circulation，2017，135（8）：759-771．DOI：10.1161/CIRCULATIONAHA.116.025250.
［3］WANG C J，WANG Y L，LI Z X，et al．The management of LDL cholesterol and predictors of goal achievement in stroke patients in China：a cross-sectional study［J］．CNS Neurosci Ther，2016，22（7）：577-583．DOI：10.1111/cns.12543.
［4］中国卒中学会组织.中国脑血管病临床管理指南［M］．北京：人民卫生出版社，2019：1-465.
［5］TAN Y，PAN Y S，LIU L P，et al．One-year outcomes and secondary prevention in patients after acute minor stroke：results from the China National Stroke Registry［J］．Neurol Res，2017，39（6）：484-491．DOI：10.1080/01616412.2017.1322804.
［6］GAO Q，FU X，WEI J W，et al．Use of oral anticoagulation among stroke patients with atrial fibrillation in China：the ChinaQUEST （Quality Evaluation of Stroke Care and Treatment） Registry study ［J］．Int J Stroke，2013，8：150-54．DOI：10.1111/j.1747-4949.2011.00716.x.
［7］中国疾病预防控制中心.2018年中国成人烟草调查［EB/OL］．（2019-08-14）［2020-10-12］．http：//www.chinacdc.cn/jkzt/sthd_3844/slhd_4156/201908/t20190814_204616.html.
［8］李亚茹，王婧，赵丽云，等．中国成年人饮酒习惯及影响因素［J］．中华流行病学杂志，2018，39（7）：898-903．DOI：10.3760/cma.j.issn.0254-6450.2018.07.007.
LI Y R，WANG J，ZHAO L Y，et al．The drinking status and associated factors in adults in China［J］．Chin J Epidemiol，2018，39（7）：898-903．DOI：10.3760/cma.j.issn.0254-6450.2018.07.007.
［9］RATHORE S S，HINN A R，COOPER L S，et al．Characterization of incident stroke signs and symptoms：findings from the atherosclerosis risk in communities study［J］．Stroke，2002，33（11）：2718-2721．DOI：10.1161/01.str.0000035286.87503.31.
［10］ROWE F J，WRIGHT D，BRAND D，et al．A prospective profile of visual field loss following stroke：prevalence，type，rehabilitation，and outcome［J］．Biomed Res Int，2013，2013：719096．DOI：10.1155/2013/719096.
［11］PAMBAKIAN A，CURRIE J，KENNARD C.Rehabilitation strategies for patients with homonymous visual field defects［J］．J Neuroophthalmol，2005，25（2）：136-142．DOI：10.1097/01.wno.0000161661.29391.0d.
［12］FLOWERS H L，SILVER F L，FANG J，et al．The incidence，co-occurrence，and predictors of dysphagia，dysarthria，and aphasia after first-ever acute ischemic stroke［J］．J Commun Disord，2013，46（3）：238-248．DOI：10.1016/j.jcomdis.2013.04.001.
［13］FLOWERS H L，SKORETZ S A，SILVER F L，et al．Poststroke aphasia frequency，recovery，and outcomes：a systematic review and meta-analysis［J］．Arch Phys Med Rehabilitation，2016，97（12）：2188-2201.e8．DOI：10.1016/j.apmr.2016.03.006.
［14］GEEGANAGE C，BEAVAN J，ELLENDER S，et al．Interventions for dysphagia and nutritional support in acute and subacute stroke［J］．Cochrane Database Syst Rev，2012，10：CD000323．DOI：10.1002/14651858.cd000323.
［15］MEHDI Z，BIRNS J，BHALLA A.Post-stroke urinary incontinence［J］．Int J Clin Pract，2013，67（11）：1128-1137．DOI：10.1111/ijcp.12183.
［16］HARARI D，COSHALL C，RUDD A G，et al．New-onset fecal incontinence after stroke：prevalence，natural history，risk factors，and impact［J］．Stroke，2003，34（1）：144-150．DOI：10.1161/01.str.0000044169.54676.f5.
［17］JOHNSON K G，JOHNSON D C.Frequency of sleep apnea in stroke and TIA patients：a meta-analysis［J］．J Clin Sleep Med，2010，6（2）：131-137.
［18］PARK J H，OVBIAGELE B，FENG W.Stroke and sexual dysfunction-a narrative review［J］．J Neurol Sci，2015，350（1/2）：7-13．DOI：10.1016/j.jns.2015.02.001.
［19］EDMONDSON D，RICHARDSON S，FAUSETT J K，et al．Prevalence of PTSD in survivors of stroke and transient ischemic attack：a meta-analytic review［J］．PLoS One，2013，8（6）：e66435．DOI：10.1371/journal.pone.0066435.
［20］GILLESPIE D C，CADDEN A P，LEES R，et al．Prevalence of pseudobulbar affect following stroke：a systematic review and meta-analysis［J］．J Stroke Cerebrovasc Dis，2016，25（3）：688-694．DOI：10.1016/j.jstrokecerebrovasdis.2015.11.038.
［21］ROBINSON R G，JORGE R E.Post-stroke depression：a review［J］．Am J Psychiatry，2016，173（3）：221-231．DOI：10.1176/appi.ajp.2015.15030363.
［22］CAMPBELL BURTON C A，MURRAY J，HOLMES J，et al．Frequency of anxiety after stroke：a systematic review and meta-analysis of observational studies［J］．Int J Stroke，2013，8（7）：545-559．DOI：10.1111/j.1747-4949.2012.00906.x.
［23］VAN DALEN J W，VAN CHARANTE E P M，NEDERKOORN P J，et al．Poststroke apathy［J］．Stroke，2013，44（3）：851-860．DOI：10.1161/strokeaha.112.674614.
［24］QU Y J，ZHUO L，LI N，et al．Prevalence of post-stroke cognitive impairment in China：a community-based，cross-sectional study［J］．PLoS One，2015，10（4）：e0122864．DOI：10.1371/journal.pone.0122864.
［25］Management of Stroke Rehabilitation Working Group.VA/DOD Clinical practice guideline for the management of stroke rehabilitation［J］．J Rehabil Res Dev，2010，47（9）：1-43.
［26］AROWOIYA A I，ELLOKER T，KARACHI F，et al．Using the World Health Organization's Disability Assessment Schedule （2） to assess disability in community-dwelling stroke patients［J］．S Afr N J Physiother，2017，73（1）：7．DOI：10.4102/sajp.v73i1.343.
［27］WARD A B，CHEN C，NORRVING B，et al．Evaluation of the post stroke checklist：a pilot study in the united kingdom and Singapore［J］．Int J Stroke，2014，9（Suppl A100）：76-84．DOI：10.1111/ijs.12291.
［28］COUPAR F，POLLOCK A，LEGG L A，et al．Home-based therapy programmes for upper limb functional recovery following stroke［J］．Cochrane Database Syst Rev，2012（5）：CD006755．DOI：10.1002/14651858.cd006755.pub2.
［29］HANKEY G J，SPIESSER J，HAKIMI Z，et al．Rate，degree，and predictors of recovery from disability following ischemic stroke［J］．Neurology，2007，68（19）：1583-1587．DOI：10.1212/01.wnl.0000260967.77422.97.
［30］REDZUAN N S，ENGKASAN J P，MAZLAN M，et al．Effectiveness of a video-based therapy program at home after acute stroke：a randomized controlled trial［J］．Arch Phys Med Rehabil，2012，93（12）：2177-2183．DOI：10.1016/j.apmr.2012.06.025.
［31］FRYER C E，LUKER J A，MCDONNELL M N，et al．Self management programmes for quality of life in people with stroke［J］．Cochrane Database Syst Rev，2016（8）：CD010442．DOI：10.1002/14651858.cd010442.pub2.
［32］吴矿文，江滨，梁杰，等．脑卒中社区康复简易适宜技术在社区脑卒中患者中的应用及效果分析［J］．中国全科医学，2011，14（35）：4025-4027．DOI：10.3969/j.issn.1007-9572.2011.35.007.
WU K W，JIANG B，LIANG J，et al．Application and effect of appropriate technologies of community rehabilitation for stroke survivors［J］．Chinese General Practice，2011，14（35）：4025-4027．DOI：10.3969/j.issn.1007-9572.2011.35.007.
［33］中国卒中营养标准化管理专家委员会.中国卒中营养标准化管理专家共识［J］．中国卒中杂志，2020，15（6）：681-689．DOI：10.3969/j.issn.1673-5765.2020.06.019.
［34］北京神经内科学会睡眠障碍专业委员会，北京神经内科学会神经精神医学与临床心理专业委员会，中国老年学和老年医学学会睡眠科学分会.卒中相关睡眠障碍评估与管理中国专家共识［J］．中华内科杂志，2019，58（1）：17-26．DOI：10.3760/cma.j.issn.0578-1426.2019.01.004.
［35］北京高血压防治协会，北京糖尿病防治协会，北京慢性病防治与健康教育研究会，高血压联盟（中国），中国老年保健协会养老与健康专业委员会，国家老年疾病临床医学研究中心中国老年心血管病防治联盟.基层心血管病综合管理实践指南2020［J］．中国医学前沿杂志（电子版），2020，12（8）：1-73．DOI：10.12037/YXQY.2020.08-01.
［36］BASSETTI C L A，RANDERATH W，VIGNATELLI L，et al．EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of stroke［J］．Eur J Neurol，2020，27（7）：1117-1136．DOI：10.1111/ene.14201.
［37］WARNER C H，WARNER C M，APPENZELLER G N，et al．Identifying and managing posttraumatic stress disorder［J］．Am Fam Physician，2013，88（12）：827-834.
［38］中国卒中学会卒中后认知障碍研究圆桌会议专家组.中国卒中后认知障碍防治研究专家共识［J］．中国卒中杂志，2020，15（2）：158-166．DOI：10.3969/j.issn.1673-5765.2020.02.010.
［39］KERNAN W N，OVBIAGELE B，BLACK H R，et al．Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack：a guideline for healthcare professionals from the American Heart Association/ American Stroke Association ［J］．Stroke，2014，45（7）：2160-2236．DOI：10.1161/STR.0000000000000024.
［40］中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国缺血性卒中和短暂性脑缺血发作二级预防指南［J］．中华神经科杂志，2015，48（4）：258-273．DOI：10.3760/cma.j.issn.1006-7876.2015.04.003.
［41］HEMPHILL J C 3RD，GREENBERG S M，ANDERSON C S，et al．Guidelines for the Management of Spontaneous Intracerebral Hemorrhage：a Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association［J］．Stroke.2015，46（7）：2032-2060．DOI：10.1161/STR.0000000000000069.
［42］WILCOX R，BOUSSER M G，BETTERIDGE D J，et al．Effects of pioglitazone in patients with type 2 diabetes with or without previous stroke：results from PRO active （PRO spective pioglitazone clinical trial in macro vascular events 04）［J］．Stroke，2007，38（3）：865-873．DOI：10.1161/01.str.0000257974.06317.49.
［43］GROUP A C，PATEL A，MACMAHON S，et al．Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes ［J］．N Engl J Med，2008，358（24）：2560-2572．DOI：10.1056/nejmoa0802987.
［44］American Diabetes Association.Standards of medical care in diabetes——2013［J］．Diabetes Care，2013，36 （Suppl 1）：S11-66．DOI：10.2337/dc13-S011.
［45］BUSE J B，GINSBERG H N，BAKRIS G L，et al．Primary prevention of cardiovascular diseases in people with diabetes mellitus：a scientific statement from the American Heart Association and the American Diabetes Association［J］．Diabetes Care，2007，30（1）：162-172．DOI：10.2337/dc07-9917.
［46］STONE N J，ROBINSON J G，LICHTENSTEIN A H，et al．2013 ACC/AHA guideline on the treatment of b1ood cholesterol to reduce atherosclerotic cardiovascular risk in aduIts：a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ［J］． Circulation，2014，129（25 Suppl 2）：S1-45.
［47］POCOCK S J，COLLIER T J.Critical appraisal of the 2018 ACC scientific Sessions late-breaking trials from a statistician's perspective［J］．J Am Coll Cardiol，2018，71（25）：2957-2969．DOI：10.1016/j.jacc.2018.04.015.
［48］MACH F，BAIGENT C，CATAPANO A L，et al．2019 ESC/EAS Guidelines for the management of dyslipidaemias：lipid modification to reduce cardiovascular risk［J］．Eur Heart J，2020，41（1）：111-188．DOI：10.1093/eurheartj/ehz455.
［49］社区人群心血管疾病综合防治指南（试行）编审委员会，中国成人血脂异常健康管理服务试点项目委员会.社区人群心血管疾病综合防治指南（试行）［J］．中国医学前沿杂志（电子版），2017，9（1）：20-36.
［50］中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组．中国急性缺血性脑卒中诊治指南2014［J］．中华神经科杂志，2015，48（4）：246-257．
［51］WANG Y J，WANG Y L，ZHAO X Q，et al．Clopidogrel with aspirin in acute minor stroke or transient ischemic attack［J］．N Engl J Med，2013，369（1）：11-19．DOI：10.1056/NEJMoa1215340.
［52］CONNOLLY SJ，EIKELBOOM J，JOYNER C，et al．Apixaban in patients with atrial fibrillation ［J］．N Engl J Med，2011，364（9）：806-817.
［53］CONNOLLY S J，EZEKOWITZ M D，YUSUF S，et al．Dabigatran versus warfarin in patients with atrial fibrillation［J］．N Engl J Med，2009，361（12）：1139-1151．DOI：10.1056/NEJMoa0905561.
［54］GIUGLIANO R P，RUFF C T，BRAUNWALD E，et al．Edoxaban versus warfarin in patients with atrial fibrillation［J］．N Engl J Med，2013，369（22）：2093-2104．DOI：10.1056/NEJMoa1310907.
［55］GRANGER C B，ALEXANDER J H，MCMURRAY J J V，et al．Apixaban versus warfarin in patients with atrial fibrillation［J］．N Engl J Med，2011，365（11）：981-992．DOI：10.1056/NEJMoa1107039.
［56］PATEL M R，MAHAFFEY K W，GARG J，et al．Rivaroxaban versus warfarin in nonvalvular atrial fibrillation［J］．N Engl J Med，2011，365（10）：883-891．DOI：10.1056/nejmoa1009638.
［57］KERNAN W N，OVBIAGELE B，BLACK H R，et al．Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack：a guideline for healthcare professionals from the American Heart Association/American Stroke Association［J］．Stroke，2014，45（7）：2160-2236．DOI：10.1161/STR.0000000000000024.
［58］江滨．现阶段我国脑卒中流行特征及防治现状对全科医疗服务的启示和建议［J］．中国全科医学，2019，22（30）：3653-3661．DOI：10.12114/j.issn.1007-9572.2019.00.445.
JIANG B．Suggestions for domestic primary stroke care arising from epidemiological characteristics，prevention and treatment of stroke in China ［J］．Chinese General Practice，2019，22（30）：3653-3661．DOI：10.12114/j.issn.1007-9572.2019.00.445.
［59］陈盼，王拥军.中美缺血性卒中门诊医疗质量改进项目进展［J］．中国卒中杂志，2015，10（1）：84-87.
CHEN P，WANG Y J.Progress of ischemic stroke medical care quality improvement program in outpatient setting in China and the USA［J］．Chinese Journal of Stroke，2015，10（1）：84-87．
［60］BUSHNELL C D，OLSON D M，ZHAO X，et al．Secondary preventive medication persistence and adherence 1 year after stroke［J］．Neurology，2011，77（12）：1182-1190．DOI：10.1212/wnl.0b013e31822f0423.
［61］国家卫生和计划生育委员会神经内科医疗质量控制中心.中国卒中中心建设指南［J］．中国卒中杂志，2015，10（6）：499-507.
［62］严隽陶，杨佩君，吴毅，等．脑卒中居家康复上海地区专家共识［J］．上海中医药大学学报，2020，34（2）：1-10.
YAN J T，YANG P J，WU Y，et al．Expert consensus on home rehabilitation of stroke in Shanghai［J］．Academic Journal of Shanghai University of Traditional Chinese Medicine，2020，34（2）：1-10.

[1]	YANG Ling, DU Xueping. Application of Murtagh Safe Diagnostic Strategy Combined with Mind Mapping for Establishing Clinical Thinking in General Practice Teaching Clinic [J]. Chinese General Practice, 2025, 28(06): 673-680.
[2]	MA Hongyang, YUE Anna, SUN Kangyun. Familial Hypercholesterolemia: Diagnostic Differences between Domestic and Foreign Guidelines [J]. Chinese General Practice, 2025, 28(06): 655-665.
[3]	FANG Xiang, SONG Haiqi, LIAO Xiaoyang, LIU Lidi, ZHANG Peng, JIA Yu, YANG Ziyu, YANG Rong, LIU Ruhui. Recommendations for the Management of Hypertensive Disorders of Pregnancy in China: Based on the A Summary of the 2023 Society of Obstetric Medicine of Australia and New Zealand Hypertension in Pregnancy Guideline [J]. Chinese General Practice, 2025, 28(06): 649-654.
[4]	LIU Zuting, XU Minghuan, YANG Xuezhi, MO Jiali, LIU Xingyu, DU Huijie, ZHANG Huiqin, YI Yingping, KUANG Jie. Correlation between the Systemic Inflammatory Response Index and Risk of Ischemic Stroke Recurrence [J]. Chinese General Practice, 2025, 28(05): 541-547.
[5]	DU Huijie, LIU Xingyu, XU Minghuan, YANG Xuezhi, ZHANG Huiqin, MO Jiali, LU Yi, KUANG Jie. Advances in the Prognostic Prediction of Acute Ischemic Stroke: Using Machine Learning Predictive Models as an Example [J]. Chinese General Practice, 2025, 28(05): 554-560.
[6]	ZHANG Pingshu, XUE Jing, XING Aijun, WANG Lianhui, MA Qian, FU Yongshan, YUAN Xiaodong. Study on Sleep Status and Prognostic Factors in Patients with Acute Posterior Circulation Ischemic Stroke [J]. Chinese General Practice, 2025, 28(05): 548-553.
[7]	ZHOU Chenxi, LIN Beilei, TANG Shangfeng, ZHANG Zhenxiang, WANG Xiaoxuan, JIANG Hu, ZHANG Dudu, LIU Bowen, LI Xin. Construction of Conceptual Framework of Proactive Health Behavior in Stroke Patients [J]. Chinese General Practice, 2025, 28(05): 534-540.
[8]	CHEN Penggang, SUN Guoqiang, ZHANG Xi, LI Xiaoze, QIN Panpan, GAO Xing, HU Hongpu. Design of an Intelligent Health Management Platform [J]. Chinese General Practice, 2025, 28(05): 619-623.
[9]	NI Xiaojia, LIN Hao, LUO Xufei, KUANG Zhuoran, LIU Yunlan, GUO Jianwen, CHEN Yaolong, CAI Yefeng, Working Group of Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicine. Clinical Practice Guideline for the Prevention and Treatment of Stroke with Integrated Traditional Chinese and Western Medicine (2023 Edition) [J]. Chinese General Practice, 2025, 28(05): 521-533.
[10]	LI Lingqi, GAO Yinyan, ZHANG Yuqin, SUN Dingkui, WU Xinyin, ZHANG Weiru. Survey on the Status and Training Demands of Capabilities for Diagnosing and Treating Common Diseases of Primary Care General Practitioners in Hunan Province [J]. Chinese General Practice, 2025, 28(04): 443-449.
[11]	ZHAI Jiayi, LU Yuan, SHI Jianjun, YU Dehua. Effects of Programmatic Assessment in Clinical Reasoning Courses in General Practice [J]. Chinese General Practice, 2025, 28(04): 420-426.
[12]	YANG Shan, WANG Cong, WANG Liuyi. Exploration of General Practice Education in Undergraduate Medical Education from the Perspective of Healthy China [J]. Chinese General Practice, 2025, 28(04): 427-431.
[13]	JIA Honghong, DU Qiuhui, ZHANG Zichen, ZHOU Yuqiu. Study on the Application of O2O Peer Tutor Collaborative Health Management Program in Rural Diabetes Patients with Non-standard Treatment [J]. Chinese General Practice, 2025, 28(04): 476-481.
[14]	WANG Xiaoru, LI Yueping. The Mediating Effect of Core Attributes of General Practice between Basic Public Health Service and Self-management Behaviors in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(04): 470-475.
[15]	YANG Hui, WANG Yang, CHEN Qingqi, LIU Chenxi, GU Jie, ZHAO Yang, QIN Jiangmei, CAO Xinyang, Sturgiss Elizabeth, Phillips William R., XU Yanli. Applying the Consensus Reporting Items for Studies in Primary Care Checklist to Improve Reporting Quality in Primary Care Research in China [J]. Chinese General Practice, 2025, 28(04): 393-401.